Dabur India Ltd.

ACTIVE

Indiawww.dabur.comPublic14,844 employeesEstablished: 1884-01-01

Clinical Trials

9 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1884

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

21.7%

Phase 2/3

17.4%

Not Applicable

15.2%

Phase 1

8.7%

Phase 3

6.5%

Unknown

6.5%

Phase 3 4

4.3%

Phase 4

2.2%

Trial Status Distribution

Completed

78.3%

Not yet recruiting

19.6%

Recruiting

2.2%

Clinical Trials

Trials sponsored by this organization (46)

Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.

Completed

interventional

May 2020600 participants

EFFECT OF AYURVEDA IMMUNO-MODULATOR DRUGS on HEALTH OF CORONA WARRIORS

Phase 1

Not yet recruiting

observational

Mar 20201,000 participants

Page 1 of 6

Approvals

Approvals by Agency

NPRA

National Pharmaceutical Regulatory Agency

Approvals

Recent Approvals

BITREEN NEEM TABLETS

NPRA

2025-11-28

News

No news articles found

Back to Organizations

Dabur India Ltd.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (46)

Clinical study on Herbal Gummy Formulation for Health Immunity and Cognition

72-hour Moisturization of Dabur skin Care

72-hour Moisturization Activity of Dabur Multiple skin Care Formulations

Clinical study of DMH Syrup and Tablets in Problems before Menstruation

Clinical Study on Topical Head Oil Application

Efficacy assessment of skin care product

Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.

EFFECT OF AYURVEDA IMMUNO-MODULATOR DRUGS on HEALTH OF CORONA WARRIORS

Approvals

Approvals by Agency

Recent Approvals

News